-
C2 Pharma Secures C-DMF Approval for Pilocarpine Nitrate API
•
Ireland-based C2 Pharma has announced the receipt of approval for a C-DMF (drug master file) concerning its pilocarbine nitrate API. This critical active pharmaceutical ingredient (API), produced in collaboration with C2’s Brazilian partner, Anidro do Brasil, plays a vital role in the formulation of ophthalmic medications. Key Features of Pilocarpine…
